BC Platforms, a company focused on providing genomic data management and analysis solutions, announced today that it has set up a Singapore-based entity in order to head its activities in the Asia Pacific region, including China.

The company's investment plans cover establishing a team in Singapore for regional sales, customer service and R&D functions. The company is already collaborating with IntERPreT, a not-for profit, pre-competitive, engagement initiative for industry players to help develop Singapore´s national personalised medicine programme.

Nino da Silva, EVP Asia, said, 'We are excited to establish a presence in Singapore, the gateway to Asia, which is the fastest growing market within Precision Medicine. The rising middle class in this region has greater expectations for more effective, personalised medicines and we have been impressed by the strong governmental commitment to facilitate genomics related research and innovation using genomic and clinical data. Singapore provides a very vibrant and business friendly environment for us where we can recruit talent and grow our business.'